Autres langues Ion Beam Applications, SA

Actions

IBAB

BE0003766806

Equipement et technologie médicale avancés

PEA

PEA/PME

Temps réel Euronext Bruxelles 10:30:02 06/10/2026			Varia. 5j.	Varia. 1 janv.
15,68 ^EUR	+3,02 %		+1,03 %	+21,36 %

01/10	IBA et Telix renforcent leurs liens grâce à un accord visant à distribuer le QIS d’ARTMS	CI
29/09	Ion Beam Applications remporte un contrat pour un centre de protonthérapie en Italie	MT

Autres langues

01/10	IBA – TRANSPARENCY NOTIFICATION
01/10	IBA en Telix versterken samenwerking
01/10	IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®
01/10	Iba and Telix Strengthen Ties Through Agreement to Distribute Artms?S Qis
29/09	Ion Beam Applications Wins Contract for Proton Therapy Center in Italy
29/09	IBA installeert protontherapiecentrum in Rome
29/09	IBA signs contract to install the first proton therapy center in central Italy, in Rome
29/09	Ion Beam Applications S.A. Signs Contract With Istituti Fisioterapici Ospitalieri & Istituto Nazionale Tumori Regina Elena To Install The First Proton Therapy Center In Central Italy, In Rome
28/09	Penn Medicine and Iba Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
28/09	IBA presenteert samenwerking met Penn Medicine
28/09	Ion Beam Applications Enters JV for Proton Therapy, Radiation Oncology Program Development
28/09	Penn Medicine and IBA Launch Joint Venture to Advance Proton Therapy and Radiation Oncology Program Development Worldwide
27/09	IBA Launches QUASAR® Penta-Guide Performance Phantom
27/09	IBA Launches Quasar Penta-Guide Performance Phantom
25/09	Ion Beam Applications to Participate in European Environmental Project
25/09	IBA aan de slag met de bestrijding van PFAS
25/09	IBA to coordinate LIFEDESTINY, a new European LIFE project to advance sustainable PFAS remediation
08/09	IBA – TRANSPARENCY NOTIFICATION
02/09	Ion Beam Applications Joins European Environmental Initiative
02/09	IBA sluit zich aan bij het Europese PFAROS-initiatief
02/09	IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications
29/08	Indexzwaargewichten helpen Bel20 aan nieuw record
28/08	Ion Beam Applications : IFRS Interim Condensed Consolidated Financial Statements June 30, 2026
27/08	Ion Beam Applications : IBA Half Year 2026 Results Presentation
27/08	Ion Beam Applications SA Reports Earnings Results for the Half Year Ended June 30, 2026